(S)-2-acetamido-N1-((S)-1-((R)-5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-ylamino)-4-methyl-1-oxopentan-2-yl)pentanediamide

ID: ALA3747468

Chembl Id: CHEMBL3747468

PubChem CID: 127042542

Max Phase: Preclinical

Molecular Formula: C22H36N8O5S

Molecular Weight: 524.65

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)c1nccs1

Standard InChI:  InChI=1S/C22H36N8O5S/c1-12(2)11-16(30-19(34)15(28-13(3)31)6-7-17(23)32)20(35)29-14(5-4-8-27-22(24)25)18(33)21-26-9-10-36-21/h9-10,12,14-16H,4-8,11H2,1-3H3,(H2,23,32)(H,28,31)(H,29,35)(H,30,34)(H4,24,25,27)/t14-,15+,16+/m1/s1

Standard InChI Key:  DXOAHXROMGLONQ-PMPSAXMXSA-N

Alternative Forms

  1. Parent:

    ALA3747468

    ---

Associated Targets(Human)

HPN Tchem Serine protease hepsin (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

St14 Suppressor of tumorigenicity 14 protein homolog (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.65Molecular Weight (Monoisotopic): 524.2529AlogP: -0.63#Rotatable Bonds: 16
Polar Surface Area: 222.25Molecular Species: BASEHBA: 8HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.69CX Basic pKa: 11.49CX LogP: -2.38CX LogD: -4.27
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.06Np Likeness Score: -0.12

References

1. Kwon H, Kim Y, Park K, Choi SA, Son SH, Byun Y..  (2016)  Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors.,  26  (2): [PMID:26711145] [10.1016/j.bmcl.2015.12.023]

Source